Antengene readies Hong Kong listing
Antengene Corp, a clinical stage biopharmaceutical company, is set to launch the roadshow for its Hong Kong IPO next week after wrapping up pre-deal investor education, according to a source close to the listing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: